Christina R Evans1, D Leann Long2, George Howard2, Leslie A McClure3, Neil A Zakai1, Nancy S Jenny1, Brett M Kissela4, Monika M Safford5, Virginia J Howard2, Mary Cushman6. 1. Larner College of Medicine at the University of Vermont, Burlington, VT, USA. 2. University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA. 3. Drexel University School of Public Health, Philadelphia, PA, USA. 4. University of Cincinnati School of Medicine, Cincinnati, OH, USA. 5. Weill Cornell Medical College, New York, NY, USA. 6. Larner College of Medicine at the University of Vermont, Burlington, VT, USA. Electronic address: mary.cushman@uvm.edu.
Abstract
BACKGROUND: C-reactive protein (CRP) is an inflammatory biomarker used in vascular risk prediction, though with less data in people of color. Blacks have higher stroke incidence and also higher CRP than whites. We studied the association of CRP with ischemic stroke risk in blacks and whites. METHODS: REGARDS, an observational cohort study, recruited and followed 30,239 black and white Americans 45 years and older for ischemic stroke. We calculated hazard ratios and 95% CIs of ischemic stroke by CRP category (<1, 1-3, 3-10, and ≥10 mg/L) adjusted for age, sex and stroke risk factors. RESULTS: There were 292 incident ischemic strokes among blacks and 439 in whites over 6.9 years of follow-up. In whites, the risk was elevated for CRP in the range from 3 to 10 mg/L and even higher for CRP >10 mg/L, whereas in blacks, an association was only seen for CRP >10 mg/L. Considered as a continuous variable, the risk factor-adjusted hazard ratios per SD higher lnCRP were 1.18 (95% CI 1.09-1.28) overall, 1.14 (95% CI 1.00-1.29) in blacks, and 1.22 (95% CI 1.10-1.35) in whites. Spline regression analysis visually confirmed the race difference in the association. CONCLUSIONS: CRP may not be equally useful in stroke risk assessment in blacks and whites. Confirmation, similar study for coronary heart disease, and identification of reasons for these racial differences require further study.
BACKGROUND: C-reactive protein (CRP) is an inflammatory biomarker used in vascular risk prediction, though with less data in people of color. Blacks have higher stroke incidence and also higher CRP than whites. We studied the association of CRP with ischemic stroke risk in blacks and whites. METHODS: REGARDS, an observational cohort study, recruited and followed 30,239 black and white Americans 45 years and older for ischemic stroke. We calculated hazard ratios and 95% CIs of ischemic stroke by CRP category (<1, 1-3, 3-10, and ≥10 mg/L) adjusted for age, sex and stroke risk factors. RESULTS: There were 292 incident ischemic strokes among blacks and 439 in whites over 6.9 years of follow-up. In whites, the risk was elevated for CRP in the range from 3 to 10 mg/L and even higher for CRP >10 mg/L, whereas in blacks, an association was only seen for CRP >10 mg/L. Considered as a continuous variable, the risk factor-adjusted hazard ratios per SD higher lnCRP were 1.18 (95% CI 1.09-1.28) overall, 1.14 (95% CI 1.00-1.29) in blacks, and 1.22 (95% CI 1.10-1.35) in whites. Spline regression analysis visually confirmed the race difference in the association. CONCLUSIONS: CRP may not be equally useful in stroke risk assessment in blacks and whites. Confirmation, similar study for coronary heart disease, and identification of reasons for these racial differences require further study.
Authors: Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah Journal: Circulation Date: 2018-11-10 Impact factor: 29.690
Authors: Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn Journal: N Engl J Med Date: 2008-11-09 Impact factor: 91.245
Authors: Paul M Ridker; Peter Libby; Jean G MacFadyen; Tom Thuren; Christie Ballantyne; Francisco Fonseca; Wolfgang Koenig; Hiroaki Shimokawa; Brendan M Everett; Robert J Glynn Journal: Eur Heart J Date: 2018-10-07 Impact factor: 29.983
Authors: Lasha S Clarke; Elizabeth J Corwin; Anne L Dunlop; Allison Hankus; Joshua M Bradner; Sudeshna Paul; Yunshen Jiao; Alicia K Smith; Nikolay Patrushev; Jennifer G Mulle; Timothy D Read; Carol J R Hogue; Bradley D Pearce Journal: Am J Reprod Immunol Date: 2020-05-23 Impact factor: 3.886
Authors: Debora Kamin Mukaz; Neil A Zakai; Salvador Cruz-Flores; Louise D McCullough; Mary Cushman Journal: Stroke Date: 2020-10-26 Impact factor: 7.914
Authors: Radhika Gangaraju; Insu Koh; Marguerite R Irvin; Leslie Lange; Damon E Houghton; Diego Adrianzen Herrera; Monika Safford; Mary Cushman; Smita Bhatia; Neil A Zakai Journal: J Am Heart Assoc Date: 2021-09-13 Impact factor: 5.501
Authors: Miguel Arce Rentería; Sarah R Gillett; Leslie A McClure; Virginia G Wadley; Stephen P Glasser; Virginia J Howard; Brett M Kissela; Frederick W Unverzagt; Nancy S Jenny; Jennifer J Manly; Mary Cushman Journal: PLoS One Date: 2020-12-31 Impact factor: 3.240